Join G2G and the SHEPHERD Foundation for a Congressional Briefing in recognition of the 2021 Rare Cancer Day. Rare cancers compose 95 percent of all forms of cancer and almost one-third of all new cancer diagnoses.
Many rare cancers still have few therapeutic options beyond decades-old protocols for chemotherapy, surgery and radiation. These figures are particularly hard on our military, veterans, minority communities and children. Most cancers persistently lack robust data, research and funding. As a result, cancer patients are frequently misdiagnosed and suffer from inadequate treatment and clinical trial options.
Congress, along with advocacy organizations, are working to reverse these trends. We hope you will join us to learn about the challenges facing patients, researchers and drug developers, and to learn about possible solutions.